【24h】

Ribozyme- and deoxyribozyme-strategies for medical applications.

机译:用于医学应用的核酶和脱氧核酶策略。

获取原文
获取原文并翻译 | 示例
           

摘要

Ribozymes are catalytically active nucleic acids capable of site-specific cleavage of target mRNAs. They have widely been employed as tools in functional studies and for therapeutic purposes. Different classes of ribozymes distinguished by size and mechanism of action have been discovered in natural systems or obtained by in vitro selection. After an introduction to different types of ribozymes with a special focus on the hammerhead and hairpin ribozyme, major challenges in the process of developing ribozymes for medical purposes will be described in the present review. Subsequently, examples of ribozyme applications in animal models for various diseases including cancer, viral infections, rheumatoid arthritis and cardiovascular diseases will be given. The course of phase I and II clinical trials with ribozymes designed to treat patients with virus infections or cancer will be outlined. Finally, the current significance of ribozymes will be discussed in the light of the emergence of new powerful anti-mRNA strategies, particularly RNA interference (RNAi).
机译:核酶是能够对靶mRNA进行位点特异性切割的催化活性核酸。它们已被广泛用作功能研究和治疗目的的工具。在自然系统中已发现或通过体外选择获得了不同类别的核酶,这些核酶的大小和作用机理不同。在介绍了不同类型的核酶后,重点介绍了锤头和发夹状核酶,在本综述中将描述开发用于医学目的的核酶过程中的主要挑战。随后,将给出核酶在各种疾病的动物模型中的应用实例,包括癌症,病毒感染,类风湿性关节炎和心血管疾病。将概述用于治疗病毒感染或癌症患者的核酶的I和II期临床试验过程。最后,将根据新的强大的抗mRNA策略(尤其是RNA干扰(RNAi))的出现来讨论核酶的当前意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号